The Role of Interleukin-1 in the Failing Heart

[1]  M. Satoh,et al.  Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy , 1996, Virchows Archiv.

[2]  C. Long,et al.  IL-1 β Increases Abundance and Activity of the Negative Transcriptional Regulator Yin Yang-1 (YY1) in Neonatal Rat Cardiac Myocytes ☆ , 2000 .

[3]  P. Kang,et al.  Apoptosis and heart failure: A critical review of the literature. , 2000, Circulation research.

[4]  P. Robbins,et al.  Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. , 2000, Circulation.

[5]  G Baumgarten,et al.  Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Freeman,et al.  beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. , 2000, Circulation.

[7]  S. Kudoh,et al.  Up-regulation of natriuretic peptides in the ventricle of Csx/Nkx2-5 transgenic mice. , 2000, Biochemical and biophysical research communications.

[8]  A. Matsumori,et al.  Amlodipine inhibits the production of cytokines induced by ouabain. , 2000, Cytokine.

[9]  T. Horio,et al.  Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. , 2000, Hypertension.

[10]  S. Frøland,et al.  Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. , 1999, Journal of the American College of Cardiology.

[11]  D. Sawyer,et al.  Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. , 1999, Circulation research.

[12]  P. Pagliaro.  Regulation of basal myocardial function by NO. , 1999, Cardiovascular research.

[13]  P. Ruiz-Lozano,et al.  Control of segmental expression of the cardiac-restricted ankyrin repeat protein gene by distinct regulatory pathways in murine cardiogenesis. , 1999, Development.

[14]  G. Noon,et al.  Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery. , 1999, Circulation.

[15]  P. Cannon,et al.  Nitric oxide triggers programmed cell death (apoptosis) of adult rat ventricular myocytes in culture. , 1999, American journal of physiology. Heart and circulatory physiology.

[16]  A. Harken,et al.  Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. , 1999, Critical care medicine.

[17]  B. Bozkurt,et al.  Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. , 1999, Circulation.

[18]  B. Poindexter,et al.  Cytokines increase neonatal cardiac myocyte calcium concentrations: the involvement of nitric oxide and cyclic nucleotides. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[19]  A. Feldman,et al.  Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. , 1999, Cardiovascular research.

[20]  K. Webster,et al.  Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. , 1999, Circulation research.

[21]  E. Isenovic,et al.  Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. , 1999, Hypertension.

[22]  M. Lapointe,et al.  Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. , 1999, Hypertension.

[23]  A. Matsumori,et al.  Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. , 1998, Circulation.

[24]  L. O’Neill,et al.  Signal transduction pathways activated by the IL‐1 receptor family: ancient signaling machinery in mammals, insects, and plants , 1998, Journal of leukocyte biology.

[25]  J. Oyama,et al.  Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. , 1998, The Journal of clinical investigation.

[26]  D. Troyer,et al.  Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy. , 1998, The American journal of pathology.

[27]  C. Long,et al.  Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia. , 1998, Circulation research.

[28]  C. Holt,et al.  Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. , 1998, Journal of molecular and cellular cardiology.

[29]  G. Freeman,et al.  Contractile depression and expression of proinflammatory cytokines and iNOS in viral myocarditis. , 1998, The American journal of physiology.

[30]  R. Dorman,et al.  ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells. , 1998, American journal of physiology. Cell physiology.

[31]  C. Long,et al.  Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. , 1998, The American journal of physiology.

[32]  Y. Kihara,et al.  Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. , 1997, Circulation research.

[33]  A. Feldman,et al.  Interleukin-1 beta inhibits phospholamban gene expression in cultured cardiomyocytes. , 1997, Circulation research.

[34]  C. Long,et al.  Chronic hypoxia modulates the interleukin-1beta-stimulated inducible nitric oxide synthase pathway in cardiac myocytes. , 1997, Circulation.

[35]  L. Kedes,et al.  A Novel Cardiac-Restricted Target for Doxorubicin , 1997, The Journal of Biological Chemistry.

[36]  N. Bishopric,et al.  Atrial Natriuretic Peptide Induces Apoptosis in Neonatal Rat Cardiac Myocytes* , 1997, The Journal of Biological Chemistry.

[37]  R. Schwartz,et al.  Competition between negative acting YY1 versus positive acting serum response factor and tinman homologue Nkx-2.5 regulates cardiac alpha-actin promoter activity. , 1997, Molecular endocrinology.

[38]  T. King,et al.  Temporal effects of cytokines on neonatal cardiac myocyte Ca2+ transients and adenylate cyclase activity. , 1997, The American journal of physiology.

[39]  G. Dorn,et al.  Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte* , 1997, The Journal of Biological Chemistry.

[40]  Y. Zou,et al.  CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway. , 1997, Development.

[41]  S. Moncada,et al.  Expression of inducible nitric oxide synthase in human heart failure. , 1997, Circulation.

[42]  J. Loscalzo,et al.  Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation. , 1996, The American journal of physiology.

[43]  T. LeJemtel,et al.  Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. , 1996, Journal of the American College of Cardiology.

[44]  D. Longrois,et al.  Interactions between endothelin-1 and atrial natriuretic peptide influence cultured chick cardiac myocyte contractility. , 1996, European journal of pharmacology.

[45]  C. Long,et al.  Interleukin-1β Is a Negative Transcriptional Regulator of α1-Adrenergic Induced Gene Expression in Cultured Cardiac Myocytes* , 1996, The Journal of Biological Chemistry.

[46]  O. Yeǧin,et al.  Cytokines in acute rheumatic fever , 1996, European Journal of Pediatrics.

[47]  M. Yacoub,et al.  Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy , 1996, The Lancet.

[48]  P. Tsao,et al.  Expression of inducible nitric oxide synthase in human heart failure. , 1996, Circulation.

[49]  Anand Kumar,et al.  Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum , 1996, The Journal of experimental medicine.

[50]  M. Lapointe,et al.  Mechanisms of interleukin-1beta regulation of nitric oxide synthase in cardiac myocytes. , 1996, Hypertension.

[51]  D. McGiffin,et al.  Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[52]  Keiichiro Suzuki,et al.  Interleukin 1α-induced expression of manganous superoxide dismutase reduces myocardial reperfusion injury in the rat , 1995 .

[53]  G. Booz,et al.  Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. , 1995, Cardiovascular research.

[54]  M. Radomski,et al.  Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. , 1995, British heart journal.

[55]  M. Gómez-Lechón,et al.  Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. , 1995, The American journal of physiology.

[56]  N. Takahashi,et al.  Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. , 1995, The Journal of clinical investigation.

[57]  L. Bourguignon,et al.  Ryanodine Receptor-Ankyrin Interaction Regulates Internal Ca Release in Mouse T-lymphoma Cells (*) , 1995, The Journal of Biological Chemistry.

[58]  Y. Zou,et al.  EFIA/YB-1 is a component of cardiac HF-1A binding activity and positively regulates transcription of the myosin light-chain 2v gene , 1995, Molecular and cellular biology.

[59]  C. Long,et al.  Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. , 1995, The Journal of clinical investigation.

[60]  R. Swerlick,et al.  Identification and Characterization of a Novel Cytokine-inducible Nuclear Protein from Human Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.

[61]  D. Mann,et al.  Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro. , 1995, The American journal of physiology.

[62]  L. Karns,et al.  M-CAT, CArG, and Sp1 elements are required for alpha 1-adrenergic induction of the skeletal alpha-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. , 1995, The Journal of biological chemistry.

[63]  S. Takahashi,et al.  Interleukin 1 alpha-induced expression of manganous superoxide dismutase reduces myocardial reperfusion injury in the rat. , 1995, Journal of molecular and cellular cardiology.

[64]  A. Matsumori,et al.  Increased circulating cytokines in patients with myocarditis and cardiomyopathy. , 1994, British heart journal.

[65]  C. Lowenstein,et al.  Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. , 1994, The Journal of biological chemistry.

[66]  K. Matsushima,et al.  The IL‐1 receptor signaling pathway , 1994, Journal of leukocyte biology.

[67]  Y. Hirata,et al.  Induction of Nitric Oxide Synthase Gene by Interleukin‐1β in Cultured Rat Cardiocytes , 1994, Circulation.

[68]  T. Lee,et al.  Transforming growth factor-beta response elements of the skeletal alpha-actin gene. Combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. , 1994, The Journal of biological chemistry.

[69]  R. Aronson,et al.  Role of L‐Type Calcium Channel Window Current in Generating Current‐Induced Early Afterdepolarizations , 1994, Journal of cardiovascular electrophysiology.

[70]  P. Simpson,et al.  Transcriptional enhancer factor-1 in cardiac myocytes interacts with an alpha 1-adrenergic- and beta-protein kinase C-inducible element in the rat beta-myosin heavy chain promoter. , 1993, The Journal of biological chemistry.

[71]  A. Mauviel.  Cytokine regulation of metalloproteinase gene expression , 1993, Journal of cellular biochemistry.

[72]  N. Maulik,et al.  Interleukin-1 alpha preconditioning reduces myocardial ischemia reperfusion injury. , 1993, Circulation.

[73]  M. Pfahl.  Nuclear receptor/AP-1 interaction. , 1993, Endocrine reviews.

[74]  P. Herrlich,et al.  Interleukin 1 induction of the c-jun promoter. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[75]  M. Lewis,et al.  Interleukin-1 beta modulates myocardial contraction via dexamethasone sensitive production of nitric oxide. , 1993, Cardiovascular research.

[76]  J. Bereiter-Hahn,et al.  Effects of cytokines on the contractility of cultured cardiac myocytes. , 1993, International journal of immunopharmacology.

[77]  M. Downes,et al.  Characterization of the thyroid hormone response element in the skeletal alpha-actin gene: negative regulation of T3 receptor binding by the retinoid X receptor. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[78]  K. Walsh,et al.  Cardiac Muscle , 2019, Keynes & Aidley's Nerve and Muscle.

[79]  O. Hess,et al.  Decreased concentration of myofibrils and myofiber hypertrophy are structural determinants of impaired left ventricular function in patients with chronic heart diseases: a multiple logistic regression analysis. , 1992, Journal of the American College of Cardiology.

[80]  M. Sporn,et al.  Role of nitric oxide in antagonistic effects of transforming growth factor-beta and interleukin-1 beta on the beating rate of cultured cardiac myocytes. , 1992, Molecular endocrinology.

[81]  K. Chien,et al.  A ubiquitous factor (HF-1a) and a distinct muscle factor (HF-1b/MEF-2) form an E-box-independent pathway for cardiac muscle gene expression , 1992, Molecular and cellular biology.

[82]  D. Goeddel,et al.  Tumor necrosis factor-alpha pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury. , 1992, Biochemical and Biophysical Research Communications - BBRC.

[83]  G. Muscat,et al.  The human skeletal alpha-actin promoter is regulated by thyroid hormone: identification of a thyroid hormone response element. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[84]  A. Feldman,et al.  Detection of interleukin and interleukin-receptor mRNA in human heart by polymerase chain reaction. , 1991, Biochemical and biophysical research communications.

[85]  M. Pfahl,et al.  Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities , 1991, Molecular and cellular biology.

[86]  T. Lee,et al.  Activation of skeletal alpha-actin gene transcription: the cooperative formation of serum response factor-binding complexes over positive cis-acting promoter serum response elements displaces a negative-acting nuclear factor enriched in replicating myoblasts and nonmyogenic cells , 1991, Molecular and cellular biology.

[87]  D. Rohrer,et al.  Influence of thyroid hormone and retinoic acid on slow sarcoplasmic reticulum Ca2+ ATPase and myosin heavy chain alpha gene expression in cardiac myocytes. Delineation of cis-active DNA elements that confer responsiveness to thyroid hormone but not to retinoic acid. , 1991, The Journal of biological chemistry.

[88]  K. Chien,et al.  A conserved 28-base-pair element (HF-1) in the rat cardiac myosin light-chain-2 gene confers cardiac-specific and alpha-adrenergic-inducible expression in cultured neonatal rat myocardial cells , 1991, Molecular and cellular biology.

[89]  A. Harken,et al.  Interleukin 1 pretreatment decreases ischemia/reperfusion injury. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[90]  J. Hosenpud,et al.  Interleukin-1-induced myocardial depression in an isolated beating heart preparation. , 1989, The Journal of heart transplantation.

[91]  K. Dangman,et al.  Automatic and triggered impulse initiation in canine subepicardial ventricular muscle cells from border zones of 24-hour transmural infarcts. New mechanisms for malignant cardiac arrhythmias? , 1988, Circulation.

[92]  W. Kannel,et al.  Cardiac failure and sudden death in the Framingham Study. , 1988, American heart journal.

[93]  D. Levy,et al.  Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. , 1987, The American journal of cardiology.

[94]  T. Katagiri,et al.  Alterations in fine structures of myofibrils and structural proteins in patients with dilated cardiomyopathy--studies with biopsied heart tissues. , 1987, Japanese circulation journal.

[95]  B. Markham,et al.  Effects of Thyroid Hormone on α‐Actin and Myosin Heavy Chain Gene Expression in Cardiac and Skeletal Muscles of the Rat: Measurement of mRNA Content Using Synthetic Oligonucleotide Probes , 1986, Circulation research.

[96]  M. Packer,et al.  Sudden unexpected death in patients with congestive heart failure: a second frontier. , 1985, Circulation.

[97]  A. Lukas,et al.  Possible Mechanisms of Ventricular Arrhythmias Elicited by Ischemia followed by Reperfusion Studies on Isolated Canine Ventricular Tissues , 1985, Circulation research.

[98]  R. Aronson.  Afterpotentials and Triggered Activity in Hypertrophied Myocardium from Rats with Renal Hypertension , 1981, Circulation research.